View in EDS

Exquisite Sensitivity to Dual BRG1/BRM ATPase Inhibitors Reveals Broad SWI/SNF Dependencies in Acute Myeloid Leukemia.

Saved in:
Bibliographic Details
Title: Exquisite Sensitivity to Dual BRG1/BRM ATPase Inhibitors Reveals Broad SWI/SNF Dependencies in Acute Myeloid Leukemia.
Authors: Rago F; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Rodrigues LU; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Bonney M; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Sprouffske K; Novartis Institutes for Biomedical Research, Basel, Switzerland., Kurth E; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Elliott G; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Ambrose J; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Aspesi P; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Oborski J; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Chen JT; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., McDonald ER; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Mapa FA; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Ruddy DA; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Kauffmann A; Novartis Institutes for Biomedical Research, Basel, Switzerland., Abrams T; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Bhang HC; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts., Jagani Z; Novartis Institutes for Biomedical Research, Cambridge, Massachusetts.
Source: Molecular cancer research : MCR [Mol Cancer Res] 2022 Mar 01; Vol. 20 (3), pp. 361-372.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-3125
DOI:10.1158/1541-7786.MCR-21-0390